DeBoer L W, Strauss H W, Kloner R A, Rude R E, Davis R F, Maroko P R, Braunwald E
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6119-23. doi: 10.1073/pnas.77.10.6119.
Investigation of the efficacy of pharmacologic agents affecting myocardial infarct size after coronary artery occlusion is complicated by the variability of collateral flow among experimental animals which results in variability of infarct size. To overcome this difficulty, we developed an autoradiographic method to delineate the ischemic area at risk of necrosis after coronary artery occlusion and we invetigated the potential protective effect of a calcium antagonist verapamil. The left anterior descending coronary arteries of 25 barbiturate-anesthetized dogs were occluded. Thirty minutes later, highly radioactive human albumin microspheres labeled with 99mTc were injected into the left atrium. One hour after coronary artery occlusion, dogs were randomized to control or treated groups; the latter received a 0.2 mg/kg loading dose and 0.6 mg/kg per hr maintenance dose of verapamil intravenously. Eight hours after coronary artery occlusion, the dogs were killed, the hearts were excised, and the left ventricle was sectioned parallel to the atrioventricular groove; infarct size was determined planimetrically after incubation in triphenyl tetrazolium chloride. The slices were then exposed to high-speed x-ray film with image-enhancing screens. The percentage of left ventricle that was ischemic, as determined by planimetry of autoradiographs, was similar in treated and control animals (36.6 +/- 2.0% compared to 37.3 +/- 2.8%, respectively). Of the ischemic area, 92.0 +/- 4.3% was infarcted in control animals and 70.5 +/- 5.1% was infarcted in treated animals (P < 0.01). Thus, this autoradiographic method using 99mTc-labeled human albumin microspheres is useful in delineating the area of ischemia after coronary artery occlusion and in evaluating the efficacy of pharmacologic agents designed to protect ischemic myocardium. Verapamil, administered 1 hr after coronary artery occlusion, is effective in limiting infarct size.
冠状动脉闭塞后,研究影响心肌梗死面积的药物疗效时,实验动物之间侧支循环血流的变异性会导致梗死面积的变异性,从而使研究变得复杂。为克服这一困难,我们开发了一种放射自显影方法来描绘冠状动脉闭塞后有坏死风险的缺血区域,并研究了钙拮抗剂维拉帕米的潜在保护作用。对25只巴比妥麻醉的犬的左前降支冠状动脉进行闭塞。30分钟后,将用99mTc标记的高放射性人白蛋白微球注入左心房。冠状动脉闭塞1小时后,将犬随机分为对照组或治疗组;后者静脉注射0.2mg/kg的负荷剂量和0.6mg/kg每小时的维持剂量的维拉帕米。冠状动脉闭塞8小时后,处死犬,取出心脏,将左心室平行于房室沟切片;在三苯基四氮唑氯化物中孵育后,通过面积测量法确定梗死面积。然后将切片与影像增强屏一起暴露于高速X线胶片。通过放射自显影片的面积测量法确定,治疗组和对照组动物左心室缺血的百分比相似(分别为36.6±2.0%和37.3±2.8%)。在缺血区域中,对照组动物梗死的比例为92.0±4.3%,治疗组动物梗死的比例为70.5±5.1%(P<0.01)。因此,这种使用99mTc标记的人白蛋白微球的放射自显影方法可用于描绘冠状动脉闭塞后的缺血区域,并评估旨在保护缺血心肌的药物的疗效。冠状动脉闭塞1小时后给予维拉帕米可有效限制梗死面积。